Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children. Longoni G, Banwell B, Filippi M, Yeh AE Neurol Neuroimmunol Neuroinflamm. 2014 Dec; 1(4):e46. Epub 2014 Dec 11. PMID: 25520954. Abstract CommentRecommendBookmarkWatch
